Research report: Genome-wide association study identifies PPP2R2B as a modifier of positive symptom improvement in schizophrenia patients treated with aripiprazole
A six-week genome-wide association study found that the single-nucleotide polymorphism rs2125443 in PPP2R2B was significantly associated with improvement in positive ...
